| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/21/2010 | EP2208787A1 A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/21/2010 | EP2208737A1 Complement factor H-derived short consensus repeat-antibody constructs |
| 07/21/2010 | EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer |
| 07/21/2010 | EP2208735A1 Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast |
| 07/21/2010 | EP2208734A1 Food material for inhibiting the formation of osteoclast |
| 07/21/2010 | EP2208733A1 Food material for inhibiting bone resorption |
| 07/21/2010 | EP2208732A1 Deshydroxy vancomycin, the preparation, pharmaceutical composition and the use |
| 07/21/2010 | EP2207810A1 Compositions affecting hyaluronic acid mediated activity |
| 07/21/2010 | EP2207802A2 Intranasal administration of active agents to the central nervous system |
| 07/21/2010 | EP2207800A1 A protease-sensitive site in apolipoprotein a1, therapeutic and diagnostic implications |
| 07/21/2010 | EP2207797A1 Modulation of sirpalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 07/21/2010 | EP2207598A1 Methods and compositions for treating dry eye |
| 07/21/2010 | EP2207597A2 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment |
| 07/21/2010 | EP2207562A1 Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion |
| 07/21/2010 | EP2207560A2 Use of fibronectin fragment (196-203) as a therapeutic agent |
| 07/21/2010 | EP2207530A2 Sustained delivery of compstatin analogs from gels |
| 07/21/2010 | EP2207509A1 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
| 07/21/2010 | EP1809320B1 Compositions containing lipase; protease and amylase for treating pancreatic insufficiency |
| 07/21/2010 | EP1797112B1 Inhibitors of hepatitits c virus |
| 07/21/2010 | EP1786454B1 Neublastin variants |
| 07/21/2010 | EP1727901B1 Materials and methods for treatment of cancer |
| 07/21/2010 | EP1706128B1 Pharmaceutical compositions and methods for insulin treatment |
| 07/21/2010 | EP1692276B1 Method of inducing memory b cell development and terminal differentiation |
| 07/21/2010 | EP1677813B1 Angiogenic peptides and uses thereof |
| 07/21/2010 | EP1444516B1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 07/21/2010 | EP1181034B1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
| 07/21/2010 | EP1124961B9 Thrombopoietic compounds |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN1982456B China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use |
| 07/21/2010 | CN1816347B Human serum albumin-free stabilized interferon liquid formulations |
| 07/21/2010 | CN1685039B Secreted acid phosphatase (SAPM) is present only in pathogenic mycobacteria and expressed selectively at phagosomal PH |
| 07/21/2010 | CN101784564A b7-dc variants |
| 07/21/2010 | CN101784562A insulin analogues with an acyl and aklylene glycol moiety |
| 07/21/2010 | CN101784302A A modulator of nrg1 for treatment of respiratory disorders |
| 07/21/2010 | CN101784281A screening methods using g-protein coupled receptors and related compositions |
| 07/21/2010 | CN101784280A Pharmaceutical polypeptide dry powder aerosol formulation and method of preparation |
| 07/21/2010 | CN101781370A Recombination fusion protein of soluble vascular endothelial growth factor receptor and application thereof |
| 07/21/2010 | CN101781369A Recombinant human arginase fusion protein and application thereof |
| 07/21/2010 | CN101781366A Novel antibacterial peptide and preparation method and application thereof |
| 07/21/2010 | CN101781364A Interleukin-1 receptor antagonist |
| 07/21/2010 | CN101781361A Balsam pear MC-JJ2163 polypeptide analogs by microwave-enhanced solid-phase synthesis and application thereof |
| 07/21/2010 | CN101781359A Novel antibacterial peptide and preparation method and application thereof |
| 07/21/2010 | CN101781358A Novel antibacterial peptide and preparation method and application thereof |
| 07/21/2010 | CN101781357A Polypeptide for detecting human cancer cells, and application thereof |
| 07/21/2010 | CN101780271A Medicinal composition of endotoxin and lectin and application thereof |
| 07/21/2010 | CN101780270A Compound soluble powder for treating respiratory diseases of birds |
| 07/21/2010 | CN101780269A Application of cell growth factor in treatment of ulcerative diseases and pulmonary fibrosis |
| 07/21/2010 | CN101780268A Method and reagent for diagnosing, preventing and treating insulin resistance |
| 07/21/2010 | CN101780267A Platelet aggregation inhibition preparation and preparation method thereof |
| 07/21/2010 | CN101780266A Compound preparation for preventing and treating respiratory disease of livestock and poultry |
| 07/21/2010 | CN101780265A Application of whey protein peptide in the preparation of medicament, health-care food or food for accelerating growth and development and increasing your bone density |
| 07/21/2010 | CN101780033A Pre-filled recombinant human interferon injection |
| 07/21/2010 | CN101780031A Induced gel used for repairing skin wound surfaces or cervical mucosa |
| 07/21/2010 | CN101380310B Composition of bFGF modified liposome and shRNA expression vector targeting human VEGF gene and preparation method thereof |
| 07/21/2010 | CN101328481B Chrysalid pteromalid antibiotic protein Pp-AP3 and encoding nucleic acid sequence thereof |
| 07/21/2010 | CN101224187B Dual functional polymer nanometer glue bunch and preparing method and application in preparing medicine for treating second narrow blood vessel |
| 07/21/2010 | CN101212970B Combination of HCV protease inhibitors with a surfactant |
| 07/21/2010 | CN101181631B Compound prescription for preventing and improving osteosporosis as well as preparation method thereof |
| 07/21/2010 | CN101125199B Application of interleukin 2 in preparing medicine for treating rhinitis |
| 07/21/2010 | CN101015683B Application of human RTN4B protein in preparation of medicine for healing wound |
| 07/20/2010 | US7759499 used for the treatment or prevention of HCV or amelioration the symptoms of hepatitis C infection, by modulating the interaction of an HCV polypeptide with HCV proteases |
| 07/20/2010 | US7759476 Double-stranded RNAS directed to IKK-2 |
| 07/20/2010 | US7759474 used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 125P5C8 can be used in active or passive immunization |
| 07/20/2010 | US7759472 Administering platelet derived growth factor antagonist and endothelial growth factor antagonist |
| 07/20/2010 | US7759463 RNA interference pathway genes as tools for targeted genetic interference |
| 07/20/2010 | US7759398 administering encapsulated cysteamine compound to treat hypercholesterolemia, non-insulin dependent diabetes; lowering uric acid levels |
| 07/20/2010 | US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain |
| 07/20/2010 | US7759367 Pharmaceutical compositions and their uses |
| 07/20/2010 | US7759315 Treatment of ischemia/reperfusion injury of the intestine, inflammatory bowel disease, acute infective colitis or pseudomembranous colitis by parenteral administration of high density lipoprotein |
| 07/20/2010 | US7759314 Stabilizing collagen VI-deficient dystrophin-associated protein complexes (DAPCs) on the surface of a cell by contacting the cell with an effective amount of a biglycan therapeutic; treatment of muscular dystrophies |
| 07/20/2010 | US7759313 Induction method for cell differentiation |
| 07/20/2010 | US7759312 Delivery of dry formulations of octreotide |
| 07/20/2010 | US7759311 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 07/20/2010 | US7759310 Mineral collagen chelates and methods of making and using same |
| 07/20/2010 | US7759309 Treating brain tissue injury or hemorrhagic shock by administering either a digested albumin that has been treated with trypsin and has an isoelectric point of higher than 4.8 and a molecular weight of less than 30 kpa, or a gelatin having an isoelectric point of 7-9 and a molecular weight of 1-10 kpa |
| 07/20/2010 | US7759308 Polymer matrix of a linear and or star polylactide-co-glycolide containing microparticles of cyclo[{4-(NH2 C2H4 NH CO O )Pro}-Phg-DTrp-Lys-Tyr(4-Bzl)-Phe] in free form or salt form; long acting release |
| 07/20/2010 | US7759306 Methods of treating acute blood loss |
| 07/20/2010 | US7759305 Polypeptide films and methods |
| 07/20/2010 | US7759302 Peptidic sulfonamides |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7759083 Using thrombin-antithrombin III complex as tool in identifying modulators of glypican-3 expression; treating arteriosclerosis |
| 07/20/2010 | US7759082 Electroprocessed fibrin-based matrices and tissues |
| 07/20/2010 | US7759078 Diagnosis and treatment of cancer |
| 07/20/2010 | US7759068 Eukaryotic cells are treated with a polynucleotide which encodes a polypeptide which inhibits the expression or the function of proteins synthesized or secreted by tumors, and thus inhibits the increase in tissue volume or the metastasis of the tumors; for prostatic tissue |
| 07/20/2010 | US7758900 for an extracorporeal blood treatment; aqueous substitution infusion fluid comprising electrolytes but excluding magnesium and calcium, and infusion fluid comprising calcium ions and magnesium ions |
| 07/20/2010 | US7758894 Detoxified venom and constituent neurotoxins; alpha-bungarotoxin, kappa-bungarotoxin, alpha-cobratoxin, alpha-cobrotoxin, alpha-conotoxins, alpha-dendrotoxin, erabutoxin; protect from viral, bacterial, parasitic infections; administer orally, subcutaneously, intramuscularly, intravenously |
| 07/20/2010 | US7758893 Enteral compositions for the prevention and/or treatment of sepsis |
| 07/20/2010 | US7758891 Combinations and modes of administration of therapeutic agents and combination therapy |
| 07/20/2010 | US7758888 Microcapsular core encapsulated within said shell and includes at least one active ingredient whereas said shell is a microcapsular shell and includes at least one inorganic polymer obtained by a sol-gel process. |
| 07/20/2010 | US7758878 liposomes; prevents signs of aging, improves aesthetic appearance of skin, and promotes recovery from environmental stresses; extracts from rosemary, Centella, Echinacea, Alpinia |
| 07/20/2010 | US7758873 Polysaccharide containing botulinum toxin pharmaceutical compositions and uses thereof |
| 07/20/2010 | US7758872 Method of treating depression |
| 07/20/2010 | US7758871 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin |
| 07/20/2010 | US7758863 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/20/2010 | US7758862 Hepatocyte growth factor receptor splice variants and methods of using same |
| 07/20/2010 | US7758860 Immunoglobulin mixture for use in treatment of muscular dystrophy, cachexia and Type II diabetes |
| 07/20/2010 | US7758856 Bacteriophage for the treatment of bacterial biofilms |
| 07/20/2010 | US7758852 OX40R binding agents |
| 07/20/2010 | US7758533 Filter to remove an ultrafiltrate from a blood stream , a therapeutic agent to treat the Inflammatory Mediator Related Disease; and a device containing adsorbent material to receive the ultrafiltrate from the hemofilter and to remove an inflammatory mediator |
| 07/20/2010 | CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis |